MedTrace Logo

Identification of Spine Structures by Using BIP-Needles

NCT02602912 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2019-02-27

No results posted yet for this study

Summary

The main purpose of the study is to assess the feasibility and clinical performance of impedance based tissue identification in various spine structures.

Conditions

  • Spinal Puncture

Interventions

DEVICE

Injeq Bioimpedance Probe (BIP) Needle

Injeq Bioimpedance Probe (BIP) Needle is a spinal needle that has bioimpedance measurement capability. It consists of traditional needle cannulae and removable bioimpedance probe which enables the measurement of bioimpedance. The needle is connected to measurement device and tissue identifying algorithm. Bioimpedance is measured during the operation and the algorithm detects when the needle tip is in contact with cerebrospinal fluid.

Sponsors & Collaborators

  • Injeq Ltd

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02602912 on ClinicalTrials.gov